| CPC C07K 16/44 (2013.01) [C07K 16/065 (2013.01); C07K 16/1289 (2013.01); C12N 5/0693 (2013.01); G01N 33/12 (2013.01)] | 1 Claim |
|
1. A method for preparing a hybrid tumor cell line that secretes cyproheptadine monoclonal antibodies with Deposit Number CGMCC No. 14697, comprising:
synthesis of cyproheptadine hapten, synthesis of cyproheptadine complete antigen, animal immunization, cell fusion, cell screening and cell line establishment, the hybrid tumor cell line was obtained, and named monoclonal cell line with the Deposit Number CGMCC No. 14697;
wherein the cyproheptadine hapten is as follows:
![]() the synthesis of cyproheptadine hapten comprises:
1 the compound 1 is dissolved in methanol solution, and ethyl chloroformate is added for stirring to obtain mixture 1, wherein the molecular formula of compound 1 is as follows:
![]() 2 the mixture 1 in 1 mentioned above is cooled, and hydrochloride (HCl) is added in to obtain mixture 2, and then extracted with ethyl acetate, the extracted organic layer is concentrated, and the compound 2 is obtained;
3 an aqueous solution of potassium hydroxide is added drop by drop to the ethanol mixture of the compound 2 and stirred to get mixture 3, wherein the molecular formula of compound 2 is as follows:
![]() 4 the mixture 3 in 3 is concentrated and extracted with ethyl acetate, and the extracted organic layer is dried, and the compound 3 is obtained, wherein the molecular formula of the compound 3 is as follows:
![]() 5 the compound 3 is dissolved in tetrahydrofuran (THF) solution containing 3-chloropropionic acid, add triethylamine and stir under N2 to get mixture 4;
6 the mixture 4 in 5 is concentrated and extracted with ethyl acetate, and the extracted organic layer is dried, and the crude product of cyproheptadine hapten is obtained, after purification by silica gel chromatography (DCM/MeOH=20:1), cyproheptadine hapten was obtained.
|